Occudo Quantitative Strategies’s Ionis Pharmaceuticals IONS Stock Holding History

Occudo Quantitative Strategies’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,766	Closed	-$476K	–	1160
2022 Q3	$476K	Sell	10,766 -50,905	-83%	-$2.14M	0.04%	682
2022 Q2	$2.28M	Buy	+61,671	New	+$2.33M	0.19%	150
2022 Q1	–	Sell	-26,650	Closed	-$811K	–	1224
2021 Q4	$811K	Buy	+26,650	New	+$839K	0.07%	438
2021 Q1	–	Sell	-6,063	Closed	-$343K	–	839
2020 Q4	$343K	Buy	+6,063	New	+$302K	0.11%	363

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Occudo Quantitative Strategies's IONS Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 10,766 shares — an estimated $476K sold.

Occudo Quantitative Strategies first reported a position in IONS in Q4 2020 and held it in 4 quarters. The position peaked at $2.28M in Q2 2022. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

Occudo Quantitative Strategies reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Occudo Quantitative Strategies sold 10,766 Ionis Pharmaceuticals shares in Q4 2022, an estimated $476K.
Occudo Quantitative Strategies first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 4 quarters.
Occudo Quantitative Strategies's Ionis Pharmaceuticals position peaked at $2.28M in Q2 2022.
338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.